Thorne HealthTech, Inc.
Thorne HealthTech, Inc. (THRN) Stock Overview
Explore Thorne HealthTech, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
550.6M
P/E Ratio
34.30
EPS (TTM)
$0.39
ROE
0.12%
THRN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Thorne HealthTech, Inc. (THRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $16.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.30 and a market capitalization of 550.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.